Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06620627 · ClinicalTrials.gov registry record
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
A clinical trial of Colorectal Cancer Screening, sponsored by Natera.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06620627: Recruiting study of Colorectal Cancer Screening, sponsored by Natera.
NCT06620627 is a study of Colorectal Cancer Screening that is actively recruiting participants, run by Natera. The registered enrollment target is 5,000 participants, below the 5,620-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06620627, a study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Natera.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
Primary Outcome
To collect samples for the research use and the development of a blood-based colorectal cancer screening test in the average risk population
Conditions Studied
Study Locations (1)
Texas
- Natera - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2025-10-31 |
What NCT06620627 shows while recruiting
NCT06620627 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 5,620-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (11% lower).
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.
NCT06620627 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06620627 about?
NCT06620627 is a clinical study titled "Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection". The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
What is the current status of trial NCT06620627?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-01-26. Estimated completion is 2025-10-31.
What conditions does trial NCT06620627 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
Who is sponsoring clinical trial NCT06620627?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06620627 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06620627's enrollment target sits among peer trials
5,000 4th of 19 higher than 16 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI